Investing Ideas
/
Australian Pharmaceuticals & Biotech Sustainable Track Record

Australian Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

3 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CTE Cryosite	AU$0.74	3.5%	13.7%	AU$36.4m	n/a	PE19.8x	n/a	2.7%
NEU Neuren Pharmaceuticals	AU$14.49	-1.6%	-37.0%	AU$1.8b	AU$27.00	PE15.7x	E-22.9%	n/a
EZZ EZZ Life Science Holdings	AU$2.16	-4.8%	263.0%	AU$101.9m	AU$5.45	PE14.6x	E17.9%	1.4%

Page 1 of 1